Allosteric modulators for
human health
About us
Addex Corporate Presentation
Overview
Our people
Executive Officers
Non-Executive Directors
Contact
Privacy Policy
Careers
Pipeline
Clinical and Pre-Clinical Pipeline
Research And Development
Technology
Allosteric modulation
Publications
Partners & collaboration
Investors
Addex Corporate Presentation
Stock Data
Press releases
Ad hoc announcements (Art. 53 L.R)
Events
Financial Reports
Analyst Reports
General Meetings
SEC / SIX Filings
Guide to US ADSS for Six Shareholders
Register for email news
Corporate Governance
Contact
Media
Press releases
Contact
Press releases
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Please select year
12.03
2007
Addex and Merck & Co. Collaborate to Develop Drugs for Parkinson’s Disease
11.29
2007
Addex Pharmaceuticals Confirms Extension of Major Shareholder Lock-up
10.29
2007
Addex Presents ADX10059 GERD Data at Conference
10.01
2007
ADX10061 Smoking Cessation Data
08.17
2007
Addex Pharmaceuticals appoints Head of ADME/PK
07.25
2007
Addex Pharmaceuticals First Half 2007 Financial Results
07.18
2007
Addex First Half 2007 Financial Results Next Wednesday
05.21
2007
Addex Prices IPO Shares at CHF73, raises CHF137 million
05.16
2007
Addex appoints Head of IR and Communications
05.09
2007
Addex Launches IPO on SWX Swiss Exchange
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Next
Back